Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Casi Phrmactcls Inc (NQ: CASI )

0.3625 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 226
Open 0.3625
Bid (Size) 0.3380 (12)
Ask (Size) 0.3625 (2)
Prev. Close 0.3625
Today's Range 0.3625 - 0.3625
52wk Range 0.3101 - 1.775
Shares Outstanding 136,062,495
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
41 Stocks Moving In Monday's Mid-Day Session
Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back and get ready for another busy week of trading as we start it off with the biggest pre-market stock movers for Monday! 
Via InvestorPlace

Performance

YTD
-57.15%
-57.15%
1 Month
-39.58%
-39.58%
3 Month
-57.70%
-57.70%
6 Month
-63.03%
-63.03%
1 Year
-77.20%
-77.20%

More News

Read More
30 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
CASI Pharmaceuticals: Q1 Earnings Insights
Via Benzinga
Recap: CASI Pharmaceuticals Q1 Earnings
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
27 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
Recap: CASI Pharmaceuticals Q4 Earnings
Via Benzinga
HFCAA News: 128 Chinese Stocks the SEC Could Delist
Via InvestorPlace
Most Chinese Biotech Stocks Can Continue US Listing After New Audit Framework
Via Benzinga
Baidu, iQIYI Explore Options After US SEC Added Them To Provisional List Pending Audit Review
Via Benzinga
CASI Pharmaceuticals's Return On Capital Employed Insights
Via Benzinga
Earnings Scheduled For March 28, 2022
Via Benzinga
Earnings Outlook For CASI Pharmaceuticals
Via Benzinga
How To Attend CASI Pharmaceuticals Q4 2021 Earnings Conference Call
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Casi Pharma-Partnered BioInvent's Lead Cancer Program Gets FDA Orphan Drug Tag
Via Benzinga
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
Via Benzinga
BioInvent and CASI Pharmaceuticals Announce CTA Approval for Clinical Studies of BI-1206 in NHL in China
From BioInvent International
Via AccessWire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
Via Benzinga
Exposures Product Safety
40 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.